Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. R. Lentz, M. Cerqueira, D. Janic, C. Kempton, I. Matytsina, M. Misgav, J. Oldenburg, M. Ozelo, Michael Recht, A. Rosholm, A. Savic, T. Suzuki, A. Tiede, E. Santagostino

Research output: Contribution to journalLetter

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)e445-e449
JournalHaemophilia
Volume22
Issue number5
DOIs
StatePublished - Sep 1 2016

Fingerprint

Hemophilia A
Hemorrhage
Therapeutics
recombinant factor VIII N8

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this

Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A. / Lentz, S. R.; Cerqueira, M.; Janic, D.; Kempton, C.; Matytsina, I.; Misgav, M.; Oldenburg, J.; Ozelo, M.; Recht, Michael; Rosholm, A.; Savic, A.; Suzuki, T.; Tiede, A.; Santagostino, E.

In: Haemophilia, Vol. 22, No. 5, 01.09.2016, p. e445-e449.

Research output: Contribution to journalLetter

Lentz, SR, Cerqueira, M, Janic, D, Kempton, C, Matytsina, I, Misgav, M, Oldenburg, J, Ozelo, M, Recht, M, Rosholm, A, Savic, A, Suzuki, T, Tiede, A & Santagostino, E 2016, 'Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A', Haemophilia, vol. 22, no. 5, pp. e445-e449. https://doi.org/10.1111/hae.12990
Lentz, S. R. ; Cerqueira, M. ; Janic, D. ; Kempton, C. ; Matytsina, I. ; Misgav, M. ; Oldenburg, J. ; Ozelo, M. ; Recht, Michael ; Rosholm, A. ; Savic, A. ; Suzuki, T. ; Tiede, A. ; Santagostino, E. / Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A. In: Haemophilia. 2016 ; Vol. 22, No. 5. pp. e445-e449.
@article{03db1d82652245b298396e8c6b51fba5,
title = "Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A",
author = "Lentz, {S. R.} and M. Cerqueira and D. Janic and C. Kempton and I. Matytsina and M. Misgav and J. Oldenburg and M. Ozelo and Michael Recht and A. Rosholm and A. Savic and T. Suzuki and A. Tiede and E. Santagostino",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/hae.12990",
language = "English (US)",
volume = "22",
pages = "e445--e449",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

AU - Lentz, S. R.

AU - Cerqueira, M.

AU - Janic, D.

AU - Kempton, C.

AU - Matytsina, I.

AU - Misgav, M.

AU - Oldenburg, J.

AU - Ozelo, M.

AU - Recht, Michael

AU - Rosholm, A.

AU - Savic, A.

AU - Suzuki, T.

AU - Tiede, A.

AU - Santagostino, E.

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84990184702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990184702&partnerID=8YFLogxK

U2 - 10.1111/hae.12990

DO - 10.1111/hae.12990

M3 - Letter

VL - 22

SP - e445-e449

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 5

ER -